.png){kind=icon}
返回
Estimating Dementia Risk Using Multifactorial Prediction Models
.png){kind=icon}
OA
AI
DOI：10.1001/jamanetworkopen.2023.18132.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
IMPORTANCE The clinical value of current multifactorial algorithms for individualized assessment of dementia risk remains unclear. OBJECTIVE To evaluate the clinical value associated with 4 widely used dementia risk scores in estimating 10-year dementia risk. DESIGN, SETTING, AND PARTICIPANTS This prospective population-based UK Biobank cohort study assessed 4 dementia risk scores at baseline (2006-2010) and ascertained incident dementia during the following 10 years. Replication with a 20-year follow-up was based on the British Whitehall II study. For both analyses, participants who had no dementia at baseline, had complete data on at least 1 dementia risk score, and were linked to electronic health records from hospitalizations or mortality were included. Data analysis was conducted from July 5, 2022, to April 20, 2023. EXPOSURES Four existing dementia risk scores: the Cardiovascular Risk Factors, Aging and Dementia (CAIDE)-Clinical score, the CAIDE-APOE-supplemented score, the Brief Dementia Screening Indicator (BDSI), and the Australian National University Alzheimer Disease Risk Index (ANU-ADRI). MAIN OUTCOMES AND MEASURES Dementia was ascertained from linked electronic health records. To evaluate how well each score predicted the 10-year risk of dementia, concordance (C) statistics, detection rate, false-positive rate, and the ratio of true to false positives were calculated for each risk score and for a model including age alone. RESULTS Of 465929 UK Biobank participants without dementia at baseline (mean [SD] age, 56.5 [8.1] years; range, 38-73 years; 252778 [54.3%] female participants), 3421 were diagnosed with dementia at follow-up (7.5 per 10000 person-years). If the threshold for a positive test result was calibrated to achieve a 5% false-positive rate, all 4 risk scores detected 9% to 16% of incident dementia and therefore missed 84% to 91% (failure rate). The corresponding failure rate was 84% for a model that included age only. For a positive test result calibrated to detect at least half of future incident dementia, the ratio of true to false positives ranged between 1 to 66 (for CAIDE-APOE-supplemented) and 1 to 116 (for ANU-ADRI). For age alone, the ratio was 1 to 43. The C statistic was 0.66 (95% CI, 0.65-0.67) for the CAIDE clinical version, 0.73 (95% CI, 0.72-0.73) for the CAIDE-APOE-supplemented, 0.68 (95% CI, 0.67-0.69) for BDSI, 0.59 (95% CI, 0.58-0.60) for ANU-ADRI, and 0.79 (95% CI, 0.79-0.80) for age alone. Similar C statistics were seen for 20-year dementia risk in the Whitehall II study cohort, which included 4865 participants (mean [SD] age, 54.9 [5.9] years; 1342 [27.6%] female participants). In a subgroup analysis of same-aged participants aged 65 (1) years, discriminatory capacity of risk scores was low (C statistics between 0.52 and 0.60). CONCLUSIONS AND RELEVANCE In these cohort studies, individualized assessments of dementia risk using existing risk prediction scores had high error rates. These findings suggest that the scores were of limited value in targeting people for dementia prevention. Further research is needed to develop more accurate algorithms for estimation of dementia risk.
Keyword:
DISEASE
COHORT
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
9.7
论文数:
1.4W
被引数:
7.4W
机构
引用论文
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019全球痴呆症2019年患病率的估计和预测患病率2050年: 全球疾病负担研究2019的分析.png)
LANCET PUBLIC HEALTH
OAAI
LANCET PUBLIC HEALTHIF25.2
OAAI分享收藏Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia A Randomized Clinical Trial强化与标准血压控制对可能的痴呆的影响随机临床试验OAAI
OAAI分享收藏Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population英国生物银行参与者与普通人群的社会人口统计学和健康相关特征的比较OAAI
OAAI分享收藏DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohnʼs ColitisOAAI
OAAI分享收藏
查看更多内容